Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: Functional implications

Molecular Biology and Evolution

Volumn 30, Issue 9, 2013, Pages 2157-2167

  Tarazona Santos, Eduardo ^a,b   MacHado, Moara ^b   Magalhães, Wagner C S ^b   Chen, Renee ^a   Lyon, Fernanda ^b   Burdett, Laurie ^a,c   Crenshaw, Andrew ^a,c   Fabbri, Cristina ^d   Pereira, Latife ^b   Pinto, Laelia ^b   Redondo, Rodrigo A F ^e   Sestanovich, Ben ^a   Yeager, Meredith ^a,c   Chanock, Stephen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

Author keywords

chronic granulomatous disease; immunogenetics; innate immunity

Indexed keywords

CATALASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE FUNCTION; GENE MAPPING; GENE STRUCTURE; GENETIC VARIABILITY; HAPLOTYPE; HOST PATHOGEN INTERACTION; HUMAN; MAMMALIAN GENETICS; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NATURAL SELECTION; NORMAL HUMAN; POPULATION GENETICS; SEQUENCE ANALYSIS;

EID: 84883206960     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/mst119     Document Type: Article

References (59)

1. Ayodo G, Price AL, Keinan A, Ajwang A, Otieno MF, Orago AS, Patterson N, Reich D. 2007. Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. Am J Hum Genet. 81(2):234-242.
2. Bamshad M, Wooding SP. 2003. Signatures of natural selection in the human genome. Nat Rev Genet. 4(2):99-111.
3. Bandelt H-J, Forster P, Röhl A. 1999. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 16(1):37-48.
4. Barreiro LB, Ben-Ali M, Quach H, et al. (17 co-authors). 2009. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet. 5(7):e1000562.
5. Barreiro LB, Quintana-Murci L. 2010. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet. 11(1):17-30.
6. Barrett RD, Schluter D. 2008. Adaptation from standing genetic variation. Trends Ecol Evol. 23(1):38-44.
7. Bedard K, Attar H, Bonnefont J, Jaquet V, Borel C, Plastre O, Stasia MJ, Antonarakis SE, Krause KH. 2009. Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Hum Mutat. 30(7):1123-1133.
8. Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M. 2008. Natural selection on genes that underlie human disease susceptibility. Curr Biol. 18(12):883-889.
9. Brandes RP, Kreuzer J. 2005. Vascular NADPH oxidases: molecularmechanisms of activation. Cardiovasc Res. 65(1):16-27.
10. Buckley RH. 2004. Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev. 5(Suppl A):S225-S233.
11. Bustamante CD, Fledel-Alon A, Williamson S, et al. (13 co-authors). 2005. Natural selection on protein-coding genes in the human genome. Nature 437(7062):1153-1157.
12. Bustamante J, Arias AA, Vogt G, et al. (29 co-authors). 2011. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 12(3):213-221.
13. Campbell MC, Tishkoff SA. 2008. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet. 9:403-433.
14. Chanock SJ, Roesler J, Zhan S, Hopkins P, Lee P, Barrett DT, Christensen BL, Curnutte JT, Görlach A. 2000. Genomic structure of the human p47-phox (NCF1) gene. Blood Cells Mol Dis. 26(1):37-46.
15. Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvänen AC, Rönnblom L, Behrens TW, Graham RR, Vyse TJ. 2011. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7(10):e1002341.
16. Excoffier L, Laval G, Schneider S. 2007. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online. 1:47-50.
17. Excoffier L, Ray N. 2008. Surfing during population expansions promotes genetic revolutions and structuration. Trends Ecol Evol. 23(7):347-351.
18. Ferrer-Admetlla A, Bosch E, SikoraM,Marquès-Bonet T, Ramírez-Soriano A, MuntasellA,Navarro A, Lazarus R, Calafell F, Bertranpetit J, Casals F. 2008. Balancing selection is the main force shaping the evolution of innate immunity genes. J Immunol. 181(2):1315-1322.
19. Fu YX, Li WH. 1993. Statistical tests of neutrality of mutations. Genetics 133(3):693-709.
20. The 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467(7319):1061-1073.
21. The 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56-65.
22. Guo SW, Thompson EA. 1992. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48(2):361-372.
23. Heyworth PG, Cross AR, Curnutte JT. 2003. Chronic granulomatous disease. Curr Opin Immunol. 15(5):578-584.
24. Hudson RR. 2002. Generating samples under a Wright-Fisher neutral model of genetic variation. Bioinformatics 18(2):337-338.
25. Jacob CO, EisensteinM, Dinauer MC, et al. (21 co-authors). 2012. Lupusassociated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci USA. 109(2):E59-E67.
26. Kimura M. 1974. The neutral theory of molecular evolution. Cambridge: Cambridge University Press.
27. Kosiol C, Vinar T, da Fonseca RR, Hubisz MJ, Bustamante CD, Nielsen R, Siepel A. 2008. Patterns of positive selection in six mammalian genomes. PLoS Genet. 4(8):e1000144.
28. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. 2000. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36(5):878-884.
29. Laval G, Patin E, Barreiro LB, Quintana-Murci L. 2010. Formulating a historical and demographicmodel of recent human evolution based on resequencing data from noncoding regions. PLoS One 5(4):e10284.
30. Lewontin R. 1972. The apportionment of human diversity. Evol Biol. 6: 391-398.
31. Lindblad-Toh K, Garber M, Zuk O, et al. (88 co-authors). 2011. A highresolution map of human evolutionary constraint using 29 mammals. Nature 478(7370):476-482.
32. Lodge R, Diallo TO, Descoteaux A. 2006. Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell Microbiol. 8(12):1922-1931.
33. Magalhães WC, Rodrigues MR, Silva D, Soares-Souza G, Iannini ML, Cerqueira GC, Faria-Campos AC, Tarazona-Santos E. 2012. DIVERGENOME: a bioinformatics platform to assist population genetics and genetic epidemiology studies. Genet Epidemiol. 36(4):360-367.
34. Marth JD, Grewal PK. 2008. Mammalian glycosylation in immunity. Nat Rev Immunol. 8(11):874-887.
35. McDonald JH. 1998. Improved tests for heterogeneity across a region of DNA sequence in the ratio of polymorphism to divergence. Mol Biol Evol. 15:377-384.
36. McDonald JH, KreitmanM. 1991. Adaptive protein evolution at the Adh locus in Drosophila. Nature 351(6328):652-654.
37. Nielsen R, Bustamante C, Clark AG, et al. (12 co-authors). 2005. A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol. 3(6):e170.
38. Olsson LM, Lindqvist AK, Källberg H, Padyukov L, Burkhardt H, Alfredsson L, Klareskog L, Holmdahl R. 2007. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther. 9(5):R98.
39. Packer BR, Yeager M, Burdett L, et al. (13 co-authors). 2006. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res. 34(Database issue):D617-D621.
40. Peter BM, Huerta-Sanchez E, Nielsen R. 2012. Distinguishing between selective sweeps from standing variation and from a de novo mutation. PLoS Genet. 8(10):e1003011.
41. Przeworski M, Coop G, Wall JD. 2005. The signature of positive selection on standing genetic variation. Evolution 59(11):2312-2323.
42. Ptak SE, Przeworski M. 2002. Evidence for population growth in humans is confounded by fine-scale population structure. Trends Genet. 18(11):559-563.
43. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30(17):3894-3900.
44. Rioux JD, Xavier RJ, Taylor KD, et al. (24 co-authors). 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet. 39(5):596-604.
45. Roberts RL, Hollis-Moffatt JE, Gearry RB, Kennedy MA, Barclay ML, Merriman TR. 2008. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun. 9(6):561-565.
46. Rozas J. 2009. DNA sequence polymorphism analysis using DnaSP. Methods Mol Biol. 537:337-350.
47. San José G, Fortuño A, BeloquiO, Díez J, Zalba G. 2008. NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond). 114(3):173-182.
48. Santiago HC, Gonzalez Lombana CZ, Macedo JP, et al. (12 co-authors). 2012. NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. PLoS Negl Trop Dis. 6(2):e1492.
49. Stephens M, Scheet P. 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 76(3):449-462.
50. Sumimoto H, Miyano K, Takeya R. 2005. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun. 338(1):677-686.
51. Tajima F. 1983. Evolutionary relationship of DNA sequences in finite populations. Genetics 105(2):437-460.
52. Tajima F. 1989. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123(3):585-595.
53. Tarazona-Santos E, Bernig T, Burdett L, Magalhaes WC, Fabbri C, Liao J, Redondo RA, Welch R, Yeager M, Chanock SJ. 2008. CYBB, an NADPH-oxidase gene: restricted diversity in humans and evidence for differential long-term purifying selection on transmembrane and cytosolic domains. Hum Mutat. 29(5):623-632.
54. Taylor RM, Burritt JB, Baniulis D, Foubert TR, Lord CI, Dinauer MC, Parkos CA, Jesaitis AJ. 2004. Site-specific inhibitors of NADPH oxidase activity and structural probes of flavocytochrome b: characterization of six monoclonal antibodies to the p22phox subunit. J Immunol. 173(12):7349-7357.
55. Voight BF, Kudaravalli S, Wen X, Pritchard JK. 2006. A map of recent positive selection in the human genome. PLoS Biol. 4(3):e72.
56. Watterson GA. 1975. On the number of segregating sites in genetical models without recombination. Theor Popul Biol. 7(2): 256-276.
57. Williamson SH, Hernandez R, Fledel-Alon A, Zhu L, Nielsen R, Bustamante CD. 2005. Simultaneous inference of selection and population growth from patterns of variation in the human genome. Proc Natl Acad Sci USA. 102(22):7882-7887.
58. Yang Z. 2007a. Adaptive molecular evolution. In: Balding DJ, Bishop M, Cannings C, editors. Handbook of statistical genetics, Vol. 1, 3rd ed. Susex (United Kingdom): John Wiley & Sons. p. 377-406.
59. Yang Z. 2007b. PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol. 24:1586-1591.